EAM
MLTX icon

Exome Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Exome Asset Management’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,744
Closed -$588K – 66
2023
Q4 		$588K Buy
+9,744
New +$588K 0.58% 46